Publikationen, an denen er mitarbeitet Rafael Moncada Durruti (34)

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages(Front. Immunol., (2022), 13, (832185), 10.3389/fimmu.2022.832185)

    Frontiers in Immunology

  3. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Changes in mechanical properties of adipose tissue after bariatric surgery driven by extracellular matrix remodelling and neovascularization are associated with metabolic improvements

    Acta Biomaterialia, Vol. 141, pp. 264-279

  2. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  3. Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance

    Nutrients, Vol. 14, Núm. 20

2021

  1. Decreased levels of microfibril‐associated glycoprotein (Magp)‐1 in patients with colon cancer and obesity are associated with changes in extracellular matrix remodelling

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  2. FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes

    Cellular and Molecular Immunology, Vol. 18, Núm. 10, pp. 2457-2459

  3. NLRP3 inflammasome blockade reduces adipose tissue inflammation and extracellular matrix remodeling

    Cellular and Molecular Immunology, Vol. 18, Núm. 4, pp. 1045-1057

  4. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

  5. The differential expression of the inflammasomes in adipose tissue and colon influences the development of colon cancer in a context of obesity by regulating intestinal inflammation

    Journal of Inflammation Research, Vol. 14, pp. 6431-6446

2020

  1. Dermatopontin, a novel adipokine promoting adipose tissue extracellular matrix remodelling and inflammation in obesity

    Journal of Clinical Medicine, Vol. 9, Núm. 4

  2. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes

    Metabolism: Clinical and Experimental, Vol. 108

  3. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

2019

  1. GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. Increase of the adiponectin/leptin ratio in patients with obesity and type 2 diabetes after roux-en-y gastric bypass

    Nutrients, Vol. 11, Núm. 9

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

  2. Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress

    Metabolism: Clinical and Experimental, Vol. 87, pp. 123-135

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  2. IL-32α-induced inflammation constitutes a link between obesity and colon cancer

    OncoImmunology, Vol. 6, Núm. 7